ArticleNature and science of sleep2025
Obstructive Sleep Apnea and Orofacial Myofunctional Profile in Adults: A Cross-Sectional Study.
Article in Nature and science of sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To examine the orofacial myofunctional profile and its determinants in adults with obstructive sleep apnea (OSA). Patients and Methods: A sample of 229 patients with OSA who underwent polysomnographic monitoring from June 1 to July 31, 2023, were enrolled in the study. All participants completed questionnaires, scales, and physical measurements to obtain information on general demographics, orofacial myofunction, degree of snoring, neck circumference, waist circumference, BMI, and OSA characteristics. Results: The proportions of participants with normal weight, overweight, and obesity were 24.5%, 44.1%, and 31.4%, respectively. Mild, moderate, and severe OSA patients accounted for 16.6%, 21.4%, and 62%, respectively. The median total orofacial myofunction score was 90. Larger neck circumference (r=-0.18, P=0.007), higher BMI (r=-0.216, P=0.001), and more severe OSA (r=-0.191, P=0.004) were associated with poorer orofacial myofunction. Age, obesity, diabetes, and RDI were significant predictors of total orofacial myofunction. Conclusion: All OSA patients have varying degrees of orofacial myofunction insufficiency in this study, which is more pronounced in overweight and obese individuals. The evaluation and intervention of orofacial myofunction should be emphasized in patients with OSA who are older, overweight or obese, who have comorbidities of other metabolic disorders, and who have poor PSG indicators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.